Our study revealed novel evidence for the interaction and biological effects of the lncRNA DRAIC/UCHL5/NFRKB pathway in GC, and provided new clues for the development of related diagnostic markers and targeted drugs. This evidence concerns the gene NFRKB and gastric cancer.